Method shows promise in treating sickle cell disease

11/4/2011 | Medical News Today

U.S. and Japanese researchers found that increasing expression in the proteins TR2 and TR4 boosted the level of fetal hemoglobin and reduced organ damage in mice with sickle cell disease. Some patients born with higher levels of fetal hemoglobin show less severe complications and higher survival rates, leading researchers to conclude that increasing fetal hemoglobin is one way to treat the disease, according to the study published in the Proceedings of the National Academy of Sciences.

View Full Article in:

Medical News Today

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA